Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study
A pandemic designated as Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading worldwide. Up to date, there is no efficient biomarker for the timely prediction of the disease progression in patients. To analyze the inflammatory profi...
Guardado en:
Autores principales: | Yalan Yu, Tao Liu, Liang Shao, Xinyi Li, Colin K. He, Muhammad Jamal, Yi Luo, Yingying Wang, Yanan Liu, Yufeng Shang, Yunbao Pan, Xinghuan Wang, Fuling Zhou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aeda50ee6d614fe1a96874fcbbb71bde |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot Study
por: Guido Primiano, et al.
Publicado: (2021) -
Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020) -
Role of Serum Uromodulin in the Early Diagnosis of Chronic Kidney Disease
por: Genov D., et al.
Publicado: (2021) -
The interrelationship of bone and cardiovascular remodeling biomarkers and clinical peculiarities of coronary artery disease in postmenopausal women
por: Natalia Serhiivna Mykhailovska, et al.
Publicado: (2020) -
The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis
por: Sara Fuentelsaz-Romero, et al.
Publicado: (2021)